Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Nervous System Diseases (311)
- Nursing (32)
- Medical Specialties (16)
- Family Practice Nursing (12)
- Public Health (12)
-
- Cardiovascular Diseases (8)
- Community Health and Preventive Medicine (8)
- Endocrine System Diseases (6)
- Medical Education (6)
- Nutritional and Metabolic Diseases (6)
- Primary Care (6)
- Cardiology (5)
- Family Medicine (5)
- Interprofessional Education (5)
- Public Health and Community Nursing (5)
- Geriatric Nursing (4)
- Health Information Technology (4)
- Health and Medical Administration (4)
- Pediatric Nursing (4)
- Preventive Medicine (4)
- Public Health Education and Promotion (4)
- Quality Improvement (4)
- Respiratory Tract Diseases (4)
- Mental and Social Health (3)
- Telemedicine (3)
- Virus Diseases (3)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (2)
- Community Health (2)
- Keyword
-
- Huntington's Disease (309)
- Diabetes (3)
- Hypertension (3)
- Anxiety (2)
- Screening (2)
-
- ANA (1)
- Allergy (1)
- Alzheimer's disease (1)
- Ambulatory blood pressure (1)
- American nurses association (1)
- Amniotic fluid embolism (1)
- Amyloid-beta (1)
- And National Guidelines (1)
- Asthma (1)
- Asthma Control Test (1)
- Autophagy (1)
- BMI (1)
- Barriers (1)
- Behavorial modification (1)
- Blindness prevention (1)
- Breast Cancer (1)
- COVID (1)
- COVID-19 Pandemic (1)
- Cardiac (1)
- Care Plans (1)
- Caregiver self-efficacy (1)
- Change policy (1)
- Chest pain (1)
- Chlamydia (1)
- Chronic Stress (1)
- Publication Year
- Publication
- Publication Type
Articles 61 - 90 of 343
Full-Text Articles in Diseases
Delirium In Long Term Care Rehabilitation Residents: A Correlational Retrospective Study, Rebecca Lerma-Kjonegaard
Delirium In Long Term Care Rehabilitation Residents: A Correlational Retrospective Study, Rebecca Lerma-Kjonegaard
Dissertations
Abstract Background: Delirium is associated with devastating outcomes, cognitive loss,
decreased function and an increase risk of mortality which affects patients and places a heavy burden on family and the healthcare system. The purpose of this study was to describe the relationship between select demographics, clinical characteristics, CHART- DEL-derived delirium diagnosis and ICD-10 coded discharge delirium diagnoses among Long Term Care (LTC) rehabilitation residents.
Method: A retrospective correlational design from174 LTC rehabilitation residents age 65 years or older using EMR and hard copy charts. The setting was a Southern California community hospital-based 100-bed LTC. Abstracted data included demographic characteristics (age, …
My Huntington’S Disease Sister – And A Hero Who Strives For The Unthinkable, Kenneth P. Serbin
My Huntington’S Disease Sister – And A Hero Who Strives For The Unthinkable, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
‘Let’S Talk About Huntington’S Disease’: 2019 Hd Awareness Month Kicks Off, Kenneth P. Serbin
‘Let’S Talk About Huntington’S Disease’: 2019 Hd Awareness Month Kicks Off, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Comedian Rod Man’S Heartfelt Speech, Ramona Johnston's Death Remind Us Of Urgent Need To Cure Huntington's Disease, Kenneth P. Serbin
Comedian Rod Man’S Heartfelt Speech, Ramona Johnston's Death Remind Us Of Urgent Need To Cure Huntington's Disease, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Roche: Less Frequent Dosing For Phase 3 Huntington's Clinical Trial, Easing Burden On Patients, Kenneth P. Serbin
Roche: Less Frequent Dosing For Phase 3 Huntington's Clinical Trial, Easing Burden On Patients, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Roche Ramps Up Huntington’S Disease Clinical Trial For Early-To Mid-Stage Patients, Considers Ways To Expand Research, Kenneth P. Serbin
Roche Ramps Up Huntington’S Disease Clinical Trial For Early-To Mid-Stage Patients, Considers Ways To Expand Research, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
‘We Can Now Fear Huntington’S Disease Less’: Reflections On The 14th Therapeutics Conference, Kenneth P. Serbin
‘We Can Now Fear Huntington’S Disease Less’: Reflections On The 14th Therapeutics Conference, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Chdi’S Chief Scientist: ‘Not A Time For The Huntington's Community To Rest Its Laurels', Kenneth P. Serbin
Chdi’S Chief Scientist: ‘Not A Time For The Huntington's Community To Rest Its Laurels', Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Continued Progress, But Also Caution, In The Fight Against Huntington's Disease, Kenneth P. Serbin
Continued Progress, But Also Caution, In The Fight Against Huntington's Disease, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Hacking Humans, Upgrading Homo Sapiens: The Role Of The Huntington's Disease Community And The Consequences For Life, Kenneth P. Serbin
Hacking Humans, Upgrading Homo Sapiens: The Role Of The Huntington's Disease Community And The Consequences For Life, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
A Friend Of The Huntington’S Community Receives Award For Hd Article In Influential Brazilian Magazine, Kenneth P. Serbin
A Friend Of The Huntington’S Community Receives Award For Hd Article In Influential Brazilian Magazine, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Roche Announces U.S., Canada Sites For Phase 3 Clinical Trial Of Huntington's Disease Drug, Kenneth P. Serbin
Roche Announces U.S., Canada Sites For Phase 3 Clinical Trial Of Huntington's Disease Drug, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Building Solidarity In Disease Communities’ Quest For Better Care And Treatments: A Conversation With A Young Tennis Award-Winner, Kenneth P. Serbin
Building Solidarity In Disease Communities’ Quest For Better Care And Treatments: A Conversation With A Young Tennis Award-Winner, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
This Thanksgiving, Appreciating Stable Health And New Plans For Huntington's Disease Advocacy, Kenneth P. Serbin
This Thanksgiving, Appreciating Stable Health And New Plans For Huntington's Disease Advocacy, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Roche Announces First Sites For Key Huntington’S Disease Observational Study, Kenneth P. Serbin
Roche Announces First Sites For Key Huntington’S Disease Observational Study, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Unpacking Generation Hd1, The Roche Phase 3 Huntington's Disease Clinical Trial, Kenneth P. Serbin
Unpacking Generation Hd1, The Roche Phase 3 Huntington's Disease Clinical Trial, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Roche Phase 3 Clinical Trial For Huntington’S Disease Gene-Slicing Drug To Enroll Volunteers In Early 2019, Kenneth P. Serbin
Roche Phase 3 Clinical Trial For Huntington’S Disease Gene-Slicing Drug To Enroll Volunteers In Early 2019, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
In Harriet’S Tragic Death, The Vulnerability Caused By Huntington's Disease – But Also The Story Of A Beautiful Soul, Kenneth P. Serbin
In Harriet’S Tragic Death, The Vulnerability Caused By Huntington's Disease – But Also The Story Of A Beautiful Soul, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Increasing Follow-Up In College Students With Latent Tuberculosis Infection, Emily Middleton, Dnp, Aprn, Ccrn, Kathy James, Dnsc, Aprn, Faan, Kimberly Woodruff, Md, Mph
Increasing Follow-Up In College Students With Latent Tuberculosis Infection, Emily Middleton, Dnp, Aprn, Ccrn, Kathy James, Dnsc, Aprn, Faan, Kimberly Woodruff, Md, Mph
Doctor of Nursing Practice Final Manuscripts
Around 13 million people in the United States have latent tuberculosis infection (LTBI) with a 5-10% chance of developing active tuberculosis (TB) in their lifetime if not treated (Center for Disease Control, 2015). At a University Student Health Center (SHC), there is a matriculation requirement for TB testing for students that screen as high risk. Many students have these testing requirements performed at outside clinics, including foreign clinics, and follow-up regarding education about LTBI and treatment recommendations was often missing. The purpose of this evidence-based practice (EBP) project was to increase follow-up, education, and treatment options after diagnosis of LTBI. …
Free From The Threat Of Huntington’S Disease, Our 'Miracle Baby' Turns 18, Kenneth P. Serbin
Free From The Threat Of Huntington’S Disease, Our 'Miracle Baby' Turns 18, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
New Ionis Data Show Positive Trends In Clinical Measures Of Huntington's Disease Drug Trial Volunteers, Kenneth P. Serbin
New Ionis Data Show Positive Trends In Clinical Measures Of Huntington's Disease Drug Trial Volunteers, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Nora Guthrie: We’Re All ‘Hoping Machines’ In The Fight Against Huntington's Disease, Kenneth P. Serbin
Nora Guthrie: We’Re All ‘Hoping Machines’ In The Fight Against Huntington's Disease, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Roche Gears Up For Pivotal Phase 3 Huntington’S Disease Gene-Slicing Clinical Trial, Kenneth P. Serbin
Roche Gears Up For Pivotal Phase 3 Huntington’S Disease Gene-Slicing Clinical Trial, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
In Chronicling The Quest To Cure Huntington’S Disease, A Whirlwind Of Emotions, Kenneth P. Serbin
In Chronicling The Quest To Cure Huntington’S Disease, A Whirlwind Of Emotions, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
The Best News For The Huntington's Disease Community Since The Discovery Of The Gene: Ionis Trial Data Revealed, Roche Confirms Jump To Phase 3, Kenneth P. Serbin
The Best News For The Huntington's Disease Community Since The Discovery Of The Gene: Ionis Trial Data Revealed, Roche Confirms Jump To Phase 3, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Overflow Audience At 13th Annual Huntington's Disease Therapeutics Conference, Kenneth P. Serbin
Overflow Audience At 13th Annual Huntington's Disease Therapeutics Conference, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Chdi's 13th Conference Promises Some Good News For The Huntington's Disease Community, Kenneth P. Serbin
Chdi's 13th Conference Promises Some Good News For The Huntington's Disease Community, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Faith In Each Other: Sticking Together Through The Challenges Of Huntington's Disease, Kenneth P. Serbin
Faith In Each Other: Sticking Together Through The Challenges Of Huntington's Disease, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Ionis Scientists Provide Initial Assessment Of Successful Phase 1/2a Huntington's Disease Trial And Discuss Next Steps, Kenneth P. Serbin
Ionis Scientists Provide Initial Assessment Of Successful Phase 1/2a Huntington's Disease Trial And Discuss Next Steps, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Ionis Drug Successfully Reduces Toxic Huntington’S Disease Protein, Paving Way For Phase 2 Trial Of Effect On Patients, Kenneth P. Serbin
Ionis Drug Successfully Reduces Toxic Huntington’S Disease Protein, Paving Way For Phase 2 Trial Of Effect On Patients, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.